Cargando…

Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug

BACKGROUND: Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant....

Descripción completa

Detalles Bibliográficos
Autores principales: Bashir, Muhammad Anwar, Khan, Amjad, Shah, Sayyed Ibrahim, Ullah, Majeed, Khuda, Fazli, Abbas, Muhammad, Goh, Khang Wen, Ming, Long Chiau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885879/
https://www.ncbi.nlm.nih.gov/pubmed/36726738
http://dx.doi.org/10.2147/DDDT.S377686
_version_ 1784880020128268288
author Bashir, Muhammad Anwar
Khan, Amjad
Shah, Sayyed Ibrahim
Ullah, Majeed
Khuda, Fazli
Abbas, Muhammad
Goh, Khang Wen
Ming, Long Chiau
author_facet Bashir, Muhammad Anwar
Khan, Amjad
Shah, Sayyed Ibrahim
Ullah, Majeed
Khuda, Fazli
Abbas, Muhammad
Goh, Khang Wen
Ming, Long Chiau
author_sort Bashir, Muhammad Anwar
collection PubMed
description BACKGROUND: Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant. METHODS: The liquids were adsorbed on microcrystalline cellulose, and all developed formulations were compressed using 10.5 mm shallow concave round punches. RESULTS: The resulting tablets were evaluated for different quality-control parameters at pre- and postcompression levels. Simvastatin showed better solubility in a mixture of oils and Tween 60 (10:1). All the developed formulations showed lower self-emulsification time (˂200 seconds) and higher cloud point (˃60°C). They were free of physical defects and had drug content within the acceptable range (98.5%–101%). The crushing strength of all formulations was in the range of 58–96 N, and the results of the friability test were within the range of USP (≤1). Disintegration time was within the official limits (NMT 15 min), and complete drug release was achieved within 30 min. CONCLUSION: Using commonly available excipients and machinery, SEDDS-based tablets with better dissolution profile and bioavailability can be prepared by direct compression. These S-SEDDSs could be a better alternative to conventional tablets of simvastatin.
format Online
Article
Text
id pubmed-9885879
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98858792023-01-31 Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug Bashir, Muhammad Anwar Khan, Amjad Shah, Sayyed Ibrahim Ullah, Majeed Khuda, Fazli Abbas, Muhammad Goh, Khang Wen Ming, Long Chiau Drug Des Devel Ther Original Research BACKGROUND: Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant. METHODS: The liquids were adsorbed on microcrystalline cellulose, and all developed formulations were compressed using 10.5 mm shallow concave round punches. RESULTS: The resulting tablets were evaluated for different quality-control parameters at pre- and postcompression levels. Simvastatin showed better solubility in a mixture of oils and Tween 60 (10:1). All the developed formulations showed lower self-emulsification time (˂200 seconds) and higher cloud point (˃60°C). They were free of physical defects and had drug content within the acceptable range (98.5%–101%). The crushing strength of all formulations was in the range of 58–96 N, and the results of the friability test were within the range of USP (≤1). Disintegration time was within the official limits (NMT 15 min), and complete drug release was achieved within 30 min. CONCLUSION: Using commonly available excipients and machinery, SEDDS-based tablets with better dissolution profile and bioavailability can be prepared by direct compression. These S-SEDDSs could be a better alternative to conventional tablets of simvastatin. Dove 2023-01-26 /pmc/articles/PMC9885879/ /pubmed/36726738 http://dx.doi.org/10.2147/DDDT.S377686 Text en © 2023 Bashir et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Bashir, Muhammad Anwar
Khan, Amjad
Shah, Sayyed Ibrahim
Ullah, Majeed
Khuda, Fazli
Abbas, Muhammad
Goh, Khang Wen
Ming, Long Chiau
Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug
title Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug
title_full Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug
title_fullStr Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug
title_full_unstemmed Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug
title_short Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug
title_sort development and evaluation of self-emulsifying drug-delivery system–based tablets for simvastatin, a bcs class ii drug
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885879/
https://www.ncbi.nlm.nih.gov/pubmed/36726738
http://dx.doi.org/10.2147/DDDT.S377686
work_keys_str_mv AT bashirmuhammadanwar developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug
AT khanamjad developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug
AT shahsayyedibrahim developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug
AT ullahmajeed developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug
AT khudafazli developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug
AT abbasmuhammad developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug
AT gohkhangwen developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug
AT minglongchiau developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug